Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 387

1.

A Proposal to Revise the Histopathologic Grading System of Early Oral Tongue Cancer Incorporating Tumor Budding.

Elseragy A, Salo T, Coletta RD, Kowalski LP, Haglund C, Nieminen P, Mäkitie AA, Leivo I, Almangush A.

Am J Surg Pathol. 2019 Mar 1. doi: 10.1097/PAS.0000000000001241. [Epub ahead of print]

PMID:
30829728
2.

Extracellular vesicles derived from cancer-associated fibroblasts induce the migration and invasion of oral squamous cell carcinoma.

Dourado MR, Korvala J, Åström P, De Oliveira CE, Cervigne NK, Mofatto LS, Campanella Bastos D, Pereira Messetti AC, Graner E, Paes Leme AF, Coletta RD, Salo T.

J Extracell Vesicles. 2019 Feb 13;8(1):1578525. doi: 10.1080/20013078.2019.1578525. eCollection 2019.

3.

Matrix metalloproteinase 9 inhibits the motility of highly aggressive HSC-3 oral squamous cell carcinoma cells.

Väyrynen O, Åström P, Nyberg P, Alahuhta I, Pirilä E, Vilen ST, Aikio M, Heljasvaara R, Risteli M, Sutinen M, Salo T.

Exp Cell Res. 2019 Mar 1;376(1):18-26. doi: 10.1016/j.yexcr.2019.01.018. Epub 2019 Jan 30.

PMID:
30710501
4.

The 8th Edition of the American Joint Committee on Cancer (AJCC8) Staging Manual: any improvement in the prognostication of oral tongue cancer?

Almangush A, Salo T.

Chin Clin Oncol. 2019 Jan 8. pii: cco.2018.12.04. doi: 10.21037/cco.2018.12.04. [Epub ahead of print] No abstract available.

5.

Proliferative verrucous leukoplakia and its tumor markers: Systematic review and meta-analysis.

Rintala M, Vahlberg T, Salo T, Rautava J.

Head Neck. 2018 Dec 11. doi: 10.1002/hed.25569. [Epub ahead of print] Review.

PMID:
30536498
6.

Potential role of nuclear magnetic resonance spectroscopy to identify salivary metabolite alterations in patients with head and neck cancer.

Mikkonen JJW, Singh SP, Akhi R, Salo T, Lappalainen R, González-Arriagada WA, Ajudarte Lopes M, Kullaa AM, Myllymaa S.

Oncol Lett. 2018 Nov;16(5):6795-6800. doi: 10.3892/ol.2018.9419. Epub 2018 Sep 7.

7.

The prognostic value of immune checkpoints in oral squamous cell carcinoma.

Sieviläinen M, Almahmoudi R, Al-Samadi A, Salo T, Pirinen M, Almangush A.

Oral Dis. 2018 Oct 13. doi: 10.1111/odi.12991. [Epub ahead of print] Review.

PMID:
30315712
8.

The Association Between Dental Anxiety And Psychiatric Disorders And Symptoms: A Systematic Review.

Halonen H, Nissinen J, Lehtiniemi H, Salo T, Riipinen P, Miettunen J.

Clin Pract Epidemiol Ment Health. 2018 Aug 31;14:207-222. doi: 10.2174/1745017901814010207. eCollection 2018.

9.

Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer.

Carnielli CM, Macedo CCS, De Rossi T, Granato DC, Rivera C, Domingues RR, Pauletti BA, Yokoo S, Heberle H, Busso-Lopes AF, Cervigne NK, Sawazaki-Calone I, Meirelles GV, Marchi FA, Telles GP, Minghim R, Ribeiro ACP, Brandão TB, de Castro G Jr, González-Arriagada WA, Gomes A, Penteado F, Santos-Silva AR, Lopes MA, Rodrigues PC, Sundquist E, Salo T, da Silva SD, Alaoui-Jamali MA, Graner E, Fox JW, Coletta RD, Paes Leme AF.

Nat Commun. 2018 Sep 5;9(1):3598. doi: 10.1038/s41467-018-05696-2.

10.

Fermented Lingonberry Juice Inhibits Oral Tongue Squamous Cell Carcinoma Invasion In Vitro Similarly to Curcumin.

Hoornstra D, Vesterlin J, Pärnänen P, Al-Samadi A, Zlotogorski-Hurvitz A, Vered M, Salo T.

In Vivo. 2018 Sep-Oct;32(5):1089-1095. doi: 10.21873/invivo.11350.

11.

Effects of ionizing radiation and HPSE1 inhibition on the invasion of oral tongue carcinoma cells on human extracellular matrices in vitro.

Väyrynen O, Piippo M, Jämsä H, Väisänen T, de Almeida CEB, Salo T, Missailidis S, Risteli M.

Exp Cell Res. 2018 Oct 1;371(1):151-161. doi: 10.1016/j.yexcr.2018.08.005. Epub 2018 Aug 5.

PMID:
30086306
12.

Small oral tongue cancers (≤ 4 cm in diameter) with clinically negative neck: from the 7th to the 8th edition of the American Joint Committee on Cancer.

Almangush A, Mäkitie AA, Mäkinen LK, Kauppila JH, Pukkila M, Hagström J, Laranne J, Soini Y, Kowalski LP, Grénman R, Haglund C, Coletta RD, Salo T, Leivo I.

Virchows Arch. 2018 Oct;473(4):481-487. doi: 10.1007/s00428-018-2417-y. Epub 2018 Jul 23.

PMID:
30039390
13.

Desmoglein 3 - Influence on oral carcinoma cell migration and invasion.

Hoque Apu E, Akram SU, Rissanen J, Wan H, Salo T.

Exp Cell Res. 2018 Sep 15;370(2):353-364. doi: 10.1016/j.yexcr.2018.06.037. Epub 2018 Jun 30.

14.

Meta-analytic evidence for a core problem solving network across multiple representational domains.

Bartley JE, Boeving ER, Riedel MC, Bottenhorn KL, Salo T, Eickhoff SB, Brewe E, Sutherland MT, Laird AR.

Neurosci Biobehav Rev. 2018 Sep;92:318-337. doi: 10.1016/j.neubiorev.2018.06.009. Epub 2018 Jun 23. Review.

PMID:
29944961
15.

Immune checkpoints indoleamine 2,3-dioxygenase 1 and programmed death-ligand 1 in oral mucosal dysplasia.

Sieviläinen M, Passador-Santos F, Almahmoudi R, Christopher S, Siponen M, Toppila-Salmi S, Salo T, Al-Samadi A.

J Oral Pathol Med. 2018 Sep;47(8):773-780. doi: 10.1111/jop.12737. Epub 2018 Jun 20.

PMID:
29851145
16.

High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.

Sirniö P, Tuomisto A, Tervahartiala T, Sorsa T, Klintrup K, Karhu T, Herzig KH, Mäkelä J, Karttunen TJ, Salo T, Mäkinen MJ, Väyrynen JP.

Br J Cancer. 2018 Jul;119(2):213-219. doi: 10.1038/s41416-018-0136-4. Epub 2018 May 29.

PMID:
29808017
17.

Extracellular interleukin-17F has a protective effect in oral tongue squamous cell carcinoma.

Almahmoudi R, Salem A, Sieviläinen M, Sundquist E, Almangush A, Toppila-Salmi S, Paavonen T, Salo T, Al-Samadi A.

Head Neck. 2018 Oct;40(10):2155-2165. doi: 10.1002/hed.25207. Epub 2018 May 14.

PMID:
29761594
18.
19.

Myofibroblasts in oral potentially malignant disorders: Is it related to malignant transformation?

Coletta RD, Salo T.

Oral Dis. 2018 Mar;24(1-2):84-88. doi: 10.1111/odi.12694. Review.

PMID:
29480603
20.

Reply to 'Comment on 'Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis".

Almangush A, Heikkinen I, Mäkitie AA, Coletta RD, Läärä E, Leivo I, Salo T.

Br J Cancer. 2018 Mar 6;118(5):e12. doi: 10.1038/bjc.2017.491. Epub 2018 Feb 15. No abstract available.

21.

Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.

Almangush A, Heikkinen I, Bakhti N, Mäkinen LK, Kauppila JH, Pukkila M, Hagström J, Laranne J, Soini Y, Kowalski LP, Grénman R, Haglund C, Mäkitie AA, Coletta RD, Leivo I, Salo T.

Histopathology. 2018 Jun;72(7):1128-1135. doi: 10.1111/his.13481. Epub 2018 Mar 23.

PMID:
29427291
22.

Human Tumor Tissue-Based 3D In Vitro Invasion Assays.

Åström P, Heljasvaara R, Nyberg P, Al-Samadi A, Salo T.

Methods Mol Biol. 2018;1731:213-221. doi: 10.1007/978-1-4939-7595-2_19.

PMID:
29318556
23.

Oral lichen sclerosus: a systematic review of reported cases and two new cases.

Kakko T, Salo T, Siponen MK.

Int J Dermatol. 2018 May;57(5):521-528. doi: 10.1111/ijd.13870. Epub 2018 Jan 4. Review.

PMID:
29313955
24.

Contribution of crop model structure, parameters and climate projections to uncertainty in climate change impact assessments.

Tao F, Rötter RP, Palosuo T, Gregorio Hernández Díaz-Ambrona C, Mínguez MI, Semenov MA, Kersebaum KC, Nendel C, Specka X, Hoffmann H, Ewert F, Dambreville A, Martre P, Rodríguez L, Ruiz-Ramos M, Gaiser T, Höhn JG, Salo T, Ferrise R, Bindi M, Cammarano D, Schulman AH.

Glob Chang Biol. 2018 Mar;24(3):1291-1307. doi: 10.1111/gcb.14019. Epub 2018 Jan 4.

PMID:
29245185
25.

Tumour budding in oral squamous cell carcinoma: a meta-analysis.

Almangush A, Pirinen M, Heikkinen I, Mäkitie AA, Salo T, Leivo I.

Br J Cancer. 2018 Feb 20;118(4):577-586. doi: 10.1038/bjc.2017.425. Epub 2017 Nov 30.

26.

Organotypic three-dimensional assays based on human leiomyoma-derived matrices.

Salo T, Dourado MR, Sundquist E, Apu EH, Alahuhta I, Tuomainen K, Vasara J, Al-Samadi A.

Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737). pii: 20160482. doi: 10.1098/rstb.2016.0482. Review.

27.

Fascin promotes migration and invasion and is a prognostic marker for oral squamous cell carcinoma.

Rodrigues PC, Sawazaki-Calone I, Ervolino de Oliveira C, Soares Macedo CC, Dourado MR, Cervigne NK, Miguel MC, Ferreira do Carmo A, Lambert DW, Graner E, Daniela da Silva S, Alaoui-Jamali MA, Paes Leme AF, Salo TA, Coletta RD.

Oncotarget. 2017 Aug 19;8(43):74736-74754. doi: 10.18632/oncotarget.20360. eCollection 2017 Sep 26.

28.

Clinicopathologic significance of ROCK2 expression in oral squamous cell carcinomas.

Dourado MR, de Oliveira CE, Sawazaki-Calone I, Sundquist E, Coletta RD, Salo T.

J Oral Pathol Med. 2018 Feb;47(2):121-127. doi: 10.1111/jop.12651. Epub 2017 Nov 7.

PMID:
29052912
29.

Crosstalk between tongue carcinoma cells, extracellular vesicles, and immune cells in in vitro and in vivo models.

Al-Samadi A, Awad SA, Tuomainen K, Zhao Y, Salem A, Parikka M, Salo T.

Oncotarget. 2017 May 10;8(36):60123-60134. doi: 10.18632/oncotarget.17768. eCollection 2017 Sep 1.

30.

Extracellular vesicles from oral squamous carcinoma cells display pro- and anti-angiogenic properties.

de Andrade A, de Oliveira CE, Dourado MR, Macedo C, Winck FV, Paes Leme AF, Salo T, Coletta RD, de Almeida Freitas R, Galvão HC.

Oral Dis. 2018 Jul;24(5):725-731. doi: 10.1111/odi.12765. Epub 2018 Apr 17.

PMID:
28887832
31.

Prognostic value of the immunohistochemical detection of cancer-associated fibroblasts in oral cancer: A systematic review and meta-analysis.

Dourado MR, Guerra ENS, Salo T, Lambert DW, Coletta RD.

J Oral Pathol Med. 2018 May;47(5):443-453. doi: 10.1111/jop.12623. Epub 2017 Sep 5. Review.

PMID:
28782893
32.

The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.

Åström P, Juurikka K, Hadler-Olsen ES, Svineng G, Cervigne NK, Coletta RD, Risteli J, Kauppila JH, Skarp S, Kuttner S, Oteiza A, Sutinen M, Salo T.

Br J Cancer. 2017 Sep 26;117(7):1007-1016. doi: 10.1038/bjc.2017.249. Epub 2017 Aug 3.

33.

Evaluation of the budding and depth of invasion (BD) model in oral tongue cancer biopsies.

Almangush A, Leivo I, Siponen M, Sundquist E, Mroueh R, Mäkitie AA, Soini Y, Haglund C, Nieminen P, Salo T.

Virchows Arch. 2018 Feb;472(2):231-236. doi: 10.1007/s00428-017-2212-1. Epub 2017 Aug 2.

PMID:
28766010
34.

Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis.

Almangush A, Heikkinen I, Mäkitie AA, Coletta RD, Läärä E, Leivo I, Salo T.

Br J Cancer. 2017 Sep 5;117(6):856-866. doi: 10.1038/bjc.2017.244. Epub 2017 Jul 27. Review.

35.

TLR1-10, NF-κB and p53 expression is increased in oral lichenoid disease.

Rusanen P, Marttila E, Uittamo J, Hagström J, Salo T, Rautemaa-Richardson R.

PLoS One. 2017 Jul 17;12(7):e0181361. doi: 10.1371/journal.pone.0181361. eCollection 2017.

36.

Infection and apoptosis associated with inflammation in periodontitis: An immunohistologic study.

Listyarifah D, Al-Samadi A, Salem A, Syaify A, Salo T, Tervahartiala T, Grenier D, Nordström DC, Sorsa T, Ainola M.

Oral Dis. 2017 Nov;23(8):1144-1154. doi: 10.1111/odi.12711. Epub 2017 Aug 7.

PMID:
28686335
37.

Histamine H4 receptor signalling in tongue cancer and its potential role in oral carcinogenesis - a short report.

Salem A, Almahmoudi R, Listyarifah D, Siponen M, Maaninka K, Al-Samadi A, Salo T, Eklund KK.

Cell Oncol (Dordr). 2017 Dec;40(6):621-630. doi: 10.1007/s13402-017-0336-6. Epub 2017 Jun 26.

PMID:
28653289
38.

Cross-reactive saliva IgA antibodies to oxidized LDL and periodontal pathogens in humans.

Akhi R, Wang C, Kyrklund M, Kummu O, Turunen SP, Hyvärinen K, Kullaa A, Salo T, Pussinen PJ, Hörkkö S.

J Clin Periodontol. 2017 Jul;44(7):682-691. doi: 10.1111/jcpe.12748. Epub 2017 Jun 29.

PMID:
28548243
39.

Functional network changes and cognitive control in schizophrenia.

Ray KL, Lesh TA, Howell AM, Salo TP, Ragland JD, MacDonald AW, Gold JM, Silverstein SM, Barch DM, Carter CS.

Neuroimage Clin. 2017 May 2;15:161-170. doi: 10.1016/j.nicl.2017.05.001. eCollection 2017.

40.

Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.

Magnussen SN, Hadler-Olsen E, Costea DE, Berg E, Jacobsen CC, Mortensen B, Salo T, Martinez-Zubiaurre I, Winberg JO, Uhlin-Hansen L, Svineng G.

BMC Cancer. 2017 May 19;17(1):350. doi: 10.1186/s12885-017-3349-7.

41.
42.

Improved outcomes with oral tongue squamous cell carcinoma in Finland.

Mroueh R, Haapaniemi A, Grénman R, Laranne J, Pukkila M, Almangush A, Salo T, Mäkitie A.

Head Neck. 2017 Jul;39(7):1306-1312. doi: 10.1002/hed.24744. Epub 2017 May 8.

PMID:
28481417
43.

Genome wide analysis of the evolution of Senecavirus A from swine clinical material and assembly yard environmental samples.

Xu W, Hole K, Goolia M, Pickering B, Salo T, Lung O, Nfon C.

PLoS One. 2017 May 5;12(5):e0176964. doi: 10.1371/journal.pone.0176964. eCollection 2017.

44.

Niche matters: The comparison between bone marrow stem cells and endometrial stem cells and stromal fibroblasts reveal distinct migration and cytokine profiles in response to inflammatory stimulus.

Khatun M, Sorjamaa A, Kangasniemi M, Sutinen M, Salo T, Liakka A, Lehenkari P, Tapanainen JS, Vuolteenaho O, Chen JC, Lehtonen S, Piltonen TT.

PLoS One. 2017 Apr 18;12(4):e0175986. doi: 10.1371/journal.pone.0175986. eCollection 2017.

45.

Generation, characterization, and application in serodiagnosis of recombinant swine vesicular disease virus-like particles.

Xu W, Goolia M, Salo T, Zhang Z, Yang M.

J Vet Sci. 2017 Aug 31;18(S1):361-370. doi: 10.4142/jvs.2017.18.S1.361.

46.

Postradiation Matrix Metalloproteinase-20 Expression and Its Impact on Dental Micromorphology and Radiation-Related Caries.

Gomes-Silva W, Prado-Ribeiro AC, Brandão TB, Morais-Faria K, de Castro Junior G, Mak MP, Lopes MA, Rocha MM, Salo T, Tjäderhane L, de Goes MF, Santos-Silva AR.

Caries Res. 2017;51(3):216-224. doi: 10.1159/000457806. Epub 2017 Mar 31.

PMID:
28359051
47.

Significant Role of Collagen XVII And Integrin β4 in Migration and Invasion of The Less Aggressive Squamous Cell Carcinoma Cells.

Moilanen JM, Löffek S, Kokkonen N, Salo S, Väyrynen JP, Hurskainen T, Manninen A, Riihilä P, Heljasvaara R, Franzke CW, Kähäri VM, Salo T, Mäkinen MJ, Tasanen K.

Sci Rep. 2017 Mar 22;7:45057. doi: 10.1038/srep45057.

48.

Topical tacrolimus, triamcinolone acetonide, and placebo in oral lichen planus: a pilot randomized controlled trial.

Siponen M, Huuskonen L, Kallio-Pulkkinen S, Nieminen P, Salo T.

Oral Dis. 2017 Jul;23(5):660-668. doi: 10.1111/odi.12653. Epub 2017 Mar 31.

PMID:
28168769
49.

Tenascin-C and fibronectin expression divide early stage tongue cancer into low- and high-risk groups.

Sundquist E, Kauppila JH, Veijola J, Mroueh R, Lehenkari P, Laitinen S, Risteli J, Soini Y, Kosma VM, Sawazaki-Calone I, Macedo CC, Bloigu R, Coletta RD, Salo T.

Br J Cancer. 2017 Feb 28;116(5):640-648. doi: 10.1038/bjc.2016.455. Epub 2017 Jan 17.

50.

Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study.

Jaurila H, Koivukangas V, Koskela M, Gäddnäs F, Salo S, Korvala J, Risteli M, Karhu T, Herzig KH, Salo T, Ala-Kokko TI.

J Transl Med. 2017 Jan 13;15(1):11. doi: 10.1186/s12967-016-1110-7.

Supplemental Content

Support Center